You lead the deal. We give you the firepower. CartaOS equips your CEO and Head of BD with deal benchmarking, partner intelligence, negotiation preparation, and due diligence support.
Most biotech CEOs begin building the partnering narrative after data lands. But by then, precedents have already been set. Partner landscapes have shifted. The other side of the table has had months of internal alignment while you are only getting started.
At most clinical-stage biotechs, the CEO, CFO, and a single Head of BD carry the entire deal. They do not have analysts. They do not have a deal team. The pharma company on the other side does.
Six technology-enabled services powered by proprietary predictive models and network science. Delivered as outcomes, not tools.
Comparable transactions mapped against your asset. Upfronts, milestones, royalties, and deal structures.
Pharma companies scored by strategic fit, pipeline gaps, and deal history. A strategic map, not a list.
Term ranges, precedent clauses, leverage points. Know where you sit vs. market and where to push.
Commercial terms benchmarked against precedents. Flagged clauses where terms deviate from market norms.
DD question lists, data room structuring, response preparation. Ready before partners ask.
Direct connection with your CEO, CBO, or Head of BD. 24/7 continuous support throughout the deal.
Deal-ready deliverables for your team and your advisors, powered by proprietary predictive models and network science.
Proprietary models that predict deal valuations, optimal term structures, and partnership probability, all customised to your specific asset and competitive landscape.
We map the entire biopharma partnering ecosystem as a knowledge graph connecting companies, assets, deal histories, pipeline gaps, and strategic relationships.
Our AI generates finished deliverables including benchmarking reports, negotiation briefs, due diligence question lists, and term sheet drafts, all contextualised for your specific transaction.
I have been on both sides of the deal table. The biggest gap in biotech partnering is not talent or relationships. It is infrastructure. The analytical depth, the structured deal data, the benchmarking. It takes years and dedicated teams to build. Most biotech deal teams simply do not have the time or resources to assemble that foundation while also running clinical programs and raising capital. CartaOS closes that gap by giving the people who make the decisions the analytical depth they deserve. That is the difference between negotiating and guessing.
Whether you advise on transactions or lead them, CartaOS provides the analytical depth to do it better.
Amplify the value you already deliver. CartaOS gives your partners deeper benchmarking, faster turnaround, and richer deal intelligence to bring to every client engagement. Co-branded. Seamless.
Explore the partnership →You have the science and the relationships. Whether you work with advisors or run BD in-house, CartaOS gives your team the deal infrastructure to walk into every room prepared.
Get started →"I watched biotech teams with transformative science walk into negotiations without the full picture. Not because their drugs were not extraordinary, but because they simply could not see the full deal landscape."
I build CartaOS to change that.
Anastasios Mastroanastasiou
Founder and CEO, CartaOS
Former BD and Licensing Due Diligence Lead at BioNTech SE. Transactions over $1B. Educated at Karolinska Institutet and Stockholm School of Economics. Research at Harvard Medical School and KAUST.
Tell us about your asset. We arm your BD team with everything they need.
You stay in the driver's seat. We arm your team with everything they need.
Therapeutic area, development stage, modality, target geographies, deal objectives.
CartaOS integrates with your CEO, CBO, or Head of BD. 24/7 support. GDPR compliant. Models customised to your deal.
Benchmarking, partner shortlist, negotiation strategy, DD prep, term sheet, and embedded support. Updated continuously.
Walk through a live example.
30-person biotech. One Head of BD. No deal team. Here is the full package.
CEO and Head of BD need a pharma partner and need to negotiate from strength. CartaOS arms their team.
For your asset. Your deal. Your timeline.